Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
In vivo–directed evolution of adeno-associated virus in the primate retina
Leah C. Byrne, Timothy P. Day, Meike Visel, Jennifer A. Strazzeri, Cécile Fortuny, Deniz Dalkara, William H. Merigan, David V. Schaffer, John G. Flannery
Leah C. Byrne, Timothy P. Day, Meike Visel, Jennifer A. Strazzeri, Cécile Fortuny, Deniz Dalkara, William H. Merigan, David V. Schaffer, John G. Flannery
View: Text | PDF
Research Article Ophthalmology

In vivo–directed evolution of adeno-associated virus in the primate retina

  • Text
  • PDF
Abstract

Efficient adeno-associated virus–mediated (AAV-mediated) gene delivery remains a significant obstacle to effective retinal gene therapies. Here, we apply directed evolution — guided by deep sequencing and followed by direct in vivo secondary selection of high-performing vectors with a GFP-barcoded library — to create AAV viral capsids with the capability to deliver genes to the outer retina in primates. A replication-incompetent library, produced via providing rep in trans, was created to mitigate risk of AAV propagation. Six rounds of in vivo selection with this library in primates — involving intravitreal library administration, recovery of genomes from outer retina, and extensive next-generation sequencing of each round — resulted in vectors with redirected tropism to the outer retina and increased gene delivery efficiency to retinal cells. These viral vectors expand the toolbox of vectors available for primate retina, and they may enable less invasive delivery of therapeutic genes to patients, potentially offering retina-wide infection at a similar dosage to vectors currently in clinical use.

Authors

Leah C. Byrne, Timothy P. Day, Meike Visel, Jennifer A. Strazzeri, Cécile Fortuny, Deniz Dalkara, William H. Merigan, David V. Schaffer, John G. Flannery

×

Figure 5

Validation of NHP#9 in primate retina.

Options: View larger image (or click on image) Download as PowerPoint
Validation of NHP#9 in primate retina.
Coinjection of approximately 1.5 ...
Coinjection of approximately 1.5 × 1012 particles of SNCG-tdTomato and approximately 1.5 × 1012 pR1.7-eGFP packaged in 7m8 and variant NHP#9 in primate retina. Intravitreal injection of 7m8 (A, C, and E) resulted in robust tdTomato expression in ganglion cells and expression of GFP in foveal cones. In contrast, injection of equal number of particles of NHP#9 in the contralateral eye resulted in reduced ganglion cell expression and increased GFP expression in cones relative to 7m8 (B, D, and F). (G and H) Quantification of ganglion cells and cones transduced with 7m8 and NHP#9 in primate retina. Counting of labeled cells, performed using Imaris software, revealed a substantial decrease in the numbers of transduced ganglion cells and an increase in the number of cones targeted with NHP#9, compared with 7m8. Scale bar: 200 μm (A and B), 100 μm (C–F), 200 μm (G and H). SNCG, gamma-synuclein gene.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts